A New Era in VWD Treatment

Click here for an informative LinkedIn/Hemostasis Today post from Shadi Tabibian, Deputy of Research at Blood Diseases Research Centers in Iran University of Medical Sciences, A New Era in VWD Treatment.

For decades, the management of VWD has relied mainly on VWF concentrates, desmopressin, antifibrinolytic agents, and hormonal therapies. Although these treatments remain effective for many patients, important unmet needs persist, including treatment burden, variable clinical response, limited prophylactic options, and reduced quality of life. A new generation of therapeutic strategies is now emerging.